Literature DB >> 7636187

V(D)J recombination and allelic exclusion of a TCR beta-chain minilocus occurs in the absence of a functional promoter.

J D Alvarez1, S J Anderson, D Y Loh.   

Abstract

Transcriptional activation of rearranging Ag receptor gene segments has been hypothesized to regulate their accessibility to V(D)J recombination. We analyzed the role of a functional promoter in the rearrangement of the murine TCR beta-chain locus using two transgenic minilocus constructs. These miniloci each contain an unrearranged V beta 8.3 gene. One has a wild-type V beta 8.3 gene, but the other has a V beta 8.3 gene with a promoter mutation that was previously shown to abrogate transcription in tissue culture. FACS analysis of thymus and lymph node cells from transgenic mouse lines showed that only the lines with the wild-type V beta 8.3 gene promoter express an 8.3 TCR beta-chain. Consistent with the protein expression data, V beta 8.3 gene transcripts were found only in the transgenic lines with the wild-type promoter. Using a quantitative PCR-based assay, it was shown that both types of transgenic lines recombine the V beta 8.3 gene at similar levels. Rearrangement of the transgenes was normal with respect to thymic development and junctional reading frame. Interestingly, both types of miniloci also underwent allelic exclusion in that recombination was blocked by the expression of a rearranged TCR beta-chain transgene. We conclude that a functional V beta gene promoter is not necessary for proper V(D)J recombination to occur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636187

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping.

Authors:  R K Tripathi; N Mathieu; S Spicuglia; D Payet; C Verthuy; G Bouvier; D Depetris; M G Mattei; W M HempeL; P Ferrier
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

3.  Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment.

Authors:  C Angelin-Duclos; K Calame
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 4.  Epigenetic control of recombination in the immune system.

Authors:  Yehudit Bergman; Howard Cedar
Journal:  Semin Immunol       Date:  2010-09-15       Impact factor: 11.130

5.  E proteins are required to activate germline transcription of the TCR Vbeta8.2 gene.

Authors:  Jingquan Jia; Meifang Dai; Yuan Zhuang
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

6.  Pax5 is required for recombination of transcribed, acetylated, 5' IgH V gene segments.

Authors:  David G T Hesslein; David L Pflugh; Dipanjan Chowdhury; Alfred L M Bothwell; Ranjan Sen; David G Schatz
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

Review 7.  Warner-Lambert/Parke-Davis Award Lecture. Pathological and physiological double-strand breaks: roles in cancer, aging, and the immune system.

Authors:  M R Lieber
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

8.  A targeted deletion of a region upstream from the Jkappa cluster impairs kappa chain rearrangement in cis in mice and in the 103/bcl2 cell line.

Authors:  L Cocea; A De Smet; M Saghatchian; S Fillatreau; L Ferradini; S Schurmans; J C Weill; C A Reynaud
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

9.  Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

Authors:  S K Durum; S Candèias; H Nakajima; W J Leonard; A M Baird; L J Berg; K Muegge
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.